How Institutional Funds Moved on PGNY

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
VANGUARD CAPITAL MANAGEMENT LLC VANGUARD CAPITAL MANAGEMENT LLC opened a new position worth $92,565,144. 2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC VANGUARD PORTFOLIO MANAGEMENT LLC opened a new position worth $144,711,176. 2026-06-30
FMR LLC FMR LLC increased this position by 89% ($76,353,830 -> $144,043,761). 2026-06-30
CITADEL ADVISORS LLC CITADEL ADVISORS LLC increased this position by 13423% ($297,150 -> $40,183,168). 2026-06-30
Sixth Street Partners Management Company, L.P. Sixth Street Partners Management Company, L.P. opened a new position worth $27,505,694. 2026-06-30
GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC increased this position by 64% ($30,039,243 -> $49,216,483). 2026-06-30
AMERICAN CENTURY COMPANIES INC AMERICAN CENTURY COMPANIES INC increased this position by 486% ($3,833,948 -> $22,453,928). 2026-06-30
VANGUARD FIDUCIARY TRUST CO VANGUARD FIDUCIARY TRUST CO opened a new position worth $14,873,282. 2026-06-30

Which Funds Hold PGNY

Largest reported positions as of 2026-06-30.

FundValueShares
VANGUARD PORTFOLIO MANAGEMENT LLC $144,711,176 5,019,465
FMR LLC $144,043,761 4,996,315
VANGUARD CAPITAL MANAGEMENT LLC $92,565,144 3,210,723
GEODE CAPITAL MANAGEMENT, LLC $49,216,483 1,706,774
Soleus Capital Management, L.P. $46,185,660 1,602,000
DIMENSIONAL FUND ADVISORS LP $43,990,198 1,525,848
CITADEL ADVISORS LLC $40,183,168 1,393,797
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $27,505,694 954,065
Sixth Street Partners Management Company, L.P. $27,505,694 954,065
WELLINGTON MANAGEMENT GROUP LLP $27,040,464 937,928

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Soleus Capital Management, L.P.: 13F Portfolio Moves Tracked Quarterly

Chart-style summary of Soleus Capital Management, L.P.'s 13F portfolio changes for the quarter ending 2026-03-31, showing new positions, increases, and exits across healthcare and biotech stocks.

Soleus Capital Management, L.P. is a healthcare-focused institutional investor whose equity holdings are disclosed each quarter through SEC Form 13F filings. This profile tracks those disclosures over time, giving a running record of the fund’s reported buys, sells, and position size changes as new 13F data becomes available. Because 13F filings only capture a quarterly … Read more